Basal forebrain volume, but not hippocampal volume, is a predictor of global cognitive decline in patients with alzheimer's disease treated with cholinesterase inhibitors

For the Alzheimer's Disease Neuroimaging Initiative, Alzheimer Precision Medicine Initiative (APMI)

Research output: Contribution to journalArticlepeer-review

9 Scopus citations

Fingerprint

Dive into the research topics of 'Basal forebrain volume, but not hippocampal volume, is a predictor of global cognitive decline in patients with alzheimer's disease treated with cholinesterase inhibitors'. Together they form a unique fingerprint.

Medicine & Life Sciences